These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
375 related items for PubMed ID: 8675188
1. Evidence that interference with binding to hepatic cytosol binders can inhibit bile acid excretion in rats. Takikawa H, Sugiyama Y, Fernandez-Checa JC, Kuhlenkamp J, Ookhtens M, Kaplowitz N. Hepatology; 1996 Jun; 23(6):1642-9. PubMed ID: 8675188 [Abstract] [Full Text] [Related]
2. Cyclical oxidation-reduction of the C3 position on bile acids catalyzed by 3 alpha-hydroxysteroid dehydrogenase. II. Studies in the prograde and retrograde single-pass, perfused rat liver and inhibition by indomethacin. Takikawa H, Ookhtens M, Stolz A, Kaplowitz N. J Clin Invest; 1987 Sep; 80(3):861-6. PubMed ID: 3476499 [Abstract] [Full Text] [Related]
3. Cyclical oxidation-reduction of the C3 position on bile acids catalyzed by rat hepatic 3 alpha-hydroxysteroid dehydrogenase. I. Studies with the purified enzyme, isolated rat hepatocytes, and inhibition by indomethacin. Takikawa H, Stolz A, Kaplowitz N. J Clin Invest; 1987 Sep; 80(3):852-60. PubMed ID: 3476498 [Abstract] [Full Text] [Related]
4. 3 alpha-hydroxysteroid dehydrogenase activity of the Y' bile acid binders in rat liver cytosol. Identification, kinetics, and physiologic significance. Stolz A, Takikawa H, Sugiyama Y, Kuhlenkamp J, Kaplowitz N. J Clin Invest; 1987 Feb; 79(2):427-34. PubMed ID: 3468121 [Abstract] [Full Text] [Related]
5. Papaverine inhibits bile acid excretion in isolated perfused rat liver. Kumai T, Hoshino M, Hayakawa T, Higashi K. Hepatology; 1994 Sep; 20(3):692-9. PubMed ID: 8076926 [Abstract] [Full Text] [Related]
6. Transport of fluorescent bile acids by the isolated perfused rat liver: kinetics, sequestration, and mobilization. Holzinger F, Schteingart CD, Ton-Nu HT, Cerrè C, Steinbach JH, Yeh HZ, Hofmann AF. Hepatology; 1998 Aug; 28(2):510-20. PubMed ID: 9696018 [Abstract] [Full Text] [Related]
7. On the kinetics of glycocholate uptake and excretion by the normal and diseased liver in man. Klapdor R. Hepatogastroenterology; 1981 Aug; 28(4):189-91. PubMed ID: 7274980 [Abstract] [Full Text] [Related]
8. Hepatobiliary excretion of bile acids and rose bengal in streptozotocin-induced and genetic diabetic rats. Stone JL, Braunstein JB, Beaty TM, Sanders RA, Watkins JB. J Pharmacol Exp Ther; 1997 Apr; 281(1):412-9. PubMed ID: 9103524 [Abstract] [Full Text] [Related]
9. Differential effects of cyclosporin A on transport of bile acids by rat hepatocytes: relationship to individual serum bile acid levels. Azer SA, Stacey NH. Toxicol Appl Pharmacol; 1994 Feb; 124(2):302-9. PubMed ID: 8122277 [Abstract] [Full Text] [Related]
10. Regulation of hepatic transport of bile salt. Effect of protein synthesis inhibition on excretion of bile salts and their binding to liver surface membrane fractions. Gonzalez MC, Sutherland E, Simon FR. J Clin Invest; 1979 Apr; 63(4):684-94. PubMed ID: 438330 [Abstract] [Full Text] [Related]
11. Human liver class I alcohol dehydrogenase gammagamma isozyme: the sole cytosolic 3beta-hydroxysteroid dehydrogenase of iso bile acids. Marschall HU, Oppermann UC, Svensson S, Nordling E, Persson B, Höög JO, Jörnvall H. Hepatology; 2000 Apr; 31(4):990-6. PubMed ID: 10733557 [Abstract] [Full Text] [Related]
12. Mechanisms of hepatic transport of cyclosporin A: an explanation for its cholestatic action? Fricker G, Fahr A. Yale J Biol Med; 1997 Apr; 70(4):379-90. PubMed ID: 9626758 [Abstract] [Full Text] [Related]
13. Primary active transport of pravastatin across the liver canalicular membrane in normal and mutant Eisai hyperbilirubinaemic rats. Yamazaki M, Kobayashi K, Sugiyama Y. Biopharm Drug Dispos; 1996 Nov; 17(8):645-59. PubMed ID: 8950045 [Abstract] [Full Text] [Related]
14. Cytotoxicity of bile salts against biliary epithelium: a study in isolated bile ductule fragments and isolated perfused rat liver. Benedetti A, Alvaro D, Bassotti C, Gigliozzi A, Ferretti G, La Rosa T, Di Sario A, Baiocchi L, Jezequel AM. Hepatology; 1997 Jul; 26(1):9-21. PubMed ID: 9214446 [Abstract] [Full Text] [Related]
15. Identification and characterization of a bile acid receptor in isolated liver surface membranes. Accatino L, Simon FR. J Clin Invest; 1976 Feb; 57(2):496-508. PubMed ID: 3520 [Abstract] [Full Text] [Related]
16. Mechanisms for the hepatic uptake and biliary excretion of tributylmethylammonium: studies with rat liver plasma membrane vesicles. Moseley RH, Smit H, Van Solkema BG, Wang W, Meijer DK. J Pharmacol Exp Ther; 1996 Feb; 276(2):561-7. PubMed ID: 8632322 [Abstract] [Full Text] [Related]
17. Structure-specific inhibition by bile acids of adenosine triphosphate-dependent taurocholate transport in rat canalicular membrane vesicles. Nishida T, Che M, Gatmaitan Z, Arias IM. Hepatology; 1995 Apr; 21(4):1058-62. PubMed ID: 7705779 [Abstract] [Full Text] [Related]
18. Primary active transport of pravastatin across the liver canalicular membrane in normal and mutant Eisai hyperbilirubinemic rats. Yamazaki M, Kobayashi K, Sugiyama Y. Biopharm Drug Dispos; 1996 Oct; 17(7):607-21. PubMed ID: 8894118 [Abstract] [Full Text] [Related]
19. Effect of indomethacin on the uptake, metabolism and excretion of 3-oxocholic acid: studies in isolated hepatocytes and perfused rat liver. Takikawa H, Fernandez-Checa JC, Kuhlenkamp J, Stolz A, Ookhtens M, Kaplowitz N. Biochim Biophys Acta; 1991 Jul 30; 1084(3):247-50. PubMed ID: 1888771 [Abstract] [Full Text] [Related]
20. Inhibition of biliary excretion of methotrexate by probenecid in rats: quantitative prediction of interaction from in vitro data. Ueda K, Kato Y, Komatsu K, Sugiyama Y. J Pharmacol Exp Ther; 2001 Jun 30; 297(3):1036-43. PubMed ID: 11356926 [Abstract] [Full Text] [Related] Page: [Next] [New Search]